Neurodegenerative diseases are a major public health problem since they aff
ect as a mean 1 % of the people in industrialized countries and will progre
ss along with the ageing of the population. For ten years, a major research
endeavour aims at developing new therapeutics against these diseases. Thes
e new approaches are based either on the substitution of affected neurons b
y homogous neuroblasts that are able to replace them anatomically and funct
ionally (fetal neural grafts), or on the we of neuroprotective proteins (by
gene therapy) that are able to promote natural defenses of neural cells. C
linical results have been obtained with fetal neural transplants over the p
ast decade, in patients with Parkinson's and more recently, Huntington's di
sease. The neuroprotective approach is under evaluation.